| Aktie | Ticker | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 5.117.574.591 $ | +466.341.338 $ | +170,5 % | 5.610.284.266 $ | +2.445.795.663 $ | +49.239,2 % | 3.463.098.749 $ | +886.603.696 $ | +74,9 % | 2.697.358.275 $ | +172.807.331 $ | +12.502,1 % | ||
| Praxis Precision Medicines, Inc. | PRAX | 655.974.329 $ | +67.677.415 $ | +11,5 % | 588.296.914 $ | +505.375.552 $ | +609,5 % | 82.921.362 $ | +51.261.034 $ | +161,9 % | 31.660.328 $ | -5.486.128 $ | -14,8 % |
| Verona Pharma plc | VRNA | 55.925.430 $ | -464.982.527 $ | -89,3 % | 520.907.957 $ | +104.201.500 $ | +25,0 % | ||||||
| Celcuity Inc. | CELC | 372.814.382 $ | +43.517.599 $ | +13,2 % | 329.296.783 $ | +174.530.832 $ | +112,8 % | 154.765.951 $ | +132.962.624 $ | +609,8 % | 21.803.327 $ | -2.079.314 $ | -8,7 % |
| Ascendis Pharma A/S | ASND | 350.281.925 $ | +119.679.711 $ | +51,9 % | 230.602.214 $ | +14.197.330 $ | +6,6 % | 216.404.884 $ | +50.038.160 $ | +30,1 % | 166.366.724 $ | +166.366.724 $ | |
| RHYTHM PHARMACEUTICALS, INC. | RYTM | 206.448.951 $ | -66.116.742 $ | -24,3 % | 272.565.693 $ | -15.824.885 $ | -5,5 % | 288.390.578 $ | +135.578.264 $ | +88,7 % | 152.812.314 $ | +17.821.182 $ | +13,2 % |
| Roivant Sciences Ltd. | ROIV | 229.507.270 $ | +56.222.766 $ | +32,4 % | 173.284.504 $ | +61.799.689 $ | +55,4 % | 111.484.815 $ | +73.939.204 $ | +196,9 % | 37.545.611 $ | +37.545.611 $ | |
| Centessa Pharmaceuticals plc | CNTA | 208.883.627 $ | +135.913.601 $ | +186,3 % | 72.970.026 $ | -2.226.848 $ | -3,0 % | 75.196.874 $ | +60.126.148 $ | +399,0 % | 15.070.726 $ | -28.650.154 $ | -65,5 % |
| Arcellx, Inc. | ACLX | 95.587.829 $ | -107.063.952 $ | -52,8 % | 202.651.781 $ | +39.475.481 $ | +24,2 % | 163.176.300 $ | -28.800.657 $ | -15,0 % | |||
| Spyre Therapeutics, Inc. | SYRE | 190.825.869 $ | +90.278.058 $ | +89,8 % | 100.547.811 $ | +79.942.313 $ | +388,0 % | 20.605.498 $ | -2.290.294 $ | -10,0 % | 22.895.792 $ | -14.428.852 $ | -38,7 % |
| Apogee Therapeutics, Inc. | APGE | 129.654.121 $ | -46.263.416 $ | -26,3 % | 175.917.537 $ | +122.203.014 $ | +227,5 % | 53.714.523 $ | +2.373.835 $ | +4,6 % | 51.340.688 $ | +9.394.113 $ | +22,4 % |
| Nuvalent, Inc. | NUVL | 161.922.737 $ | -5.570.175 $ | -3,3 % | 167.492.912 $ | +32.382.095 $ | +24,0 % | 135.110.817 $ | +30.184.583 $ | +28,8 % | 104.926.234 $ | -10.954.777 $ | -9,5 % |
| Travere Therapeutics, Inc. | TVTX | 123.075.190 $ | -40.394.068 $ | -24,7 % | 163.469.258 $ | +72.777.959 $ | +80,2 % | 90.691.299 $ | +78.344.369 $ | +634,5 % | 12.346.930 $ | +12.346.930 $ | |
| Edgewise Therapeutics, Inc. | EWTX | 139.355.181 $ | +28.730.556 $ | +26,0 % | 110.624.625 $ | +49.055.224 $ | +79,7 % | 61.569.401 $ | +739.670 $ | +1,2 % | 60.829.731 $ | -94.211.485 $ | -60,8 % |
| SPDR SER TR | 134.123.000 $ | +134.119.667 $ | +4.023.992,4 % | 24.879.000 $ | +24.875.983 $ | +824.527,1 % | |||||||
| Protagonist Therapeutics, Inc | PTGX | 129.734.647 $ | +11.788.527 $ | +10,0 % | 117.946.120 $ | +49.514.318 $ | +72,4 % | 68.431.802 $ | +9.047.061 $ | +15,2 % | 59.384.741 $ | +6.610.875 $ | +12,5 % |
| Merus N.V. | 127.393.706 $ | +90.143.648 $ | +242,0 % | 37.250.058 $ | +8.187.544 $ | +28,2 % | |||||||
| EXACT SCIENCES CORP | EXAS | 121.921.460 $ | +96.454.666 $ | +378,7 % | 25.466.794 $ | +25.466.794 $ | |||||||
| Amylyx Pharmaceuticals, Inc. | AMLX | 115.159.860 $ | +15.078.485 $ | +15,1 % | 100.081.375 $ | -21.581.265 $ | -17,7 % | 121.662.640 $ | +71.008.480 $ | +140,2 % | 50.654.160 $ | +22.778.968 $ | +81,7 % |
| Inhibrx Biosciences, Inc. | INBX | 96.993.192 $ | -17.770.661 $ | -15,5 % | 114.763.853 $ | +70.046.682 $ | +156,6 % | 44.717.171 $ | +30.762.653 $ | +220,4 % | 13.954.518 $ | -931.205 $ | -6,3 % |
| Immatics N.V. | IMTX | 102.173.207 $ | -6.853.081 $ | -6,3 % | 109.026.288 $ | +29.079.243 $ | +36,4 % | 79.947.045 $ | +29.464.052 $ | +58,4 % | 50.482.993 $ | +8.163.606 $ | +19,3 % |
| MeiraGTx Holdings plc | MGTX | 89.312.864 $ | +7.220.345 $ | +8,8 % | 82.092.519 $ | -21.700.021 $ | -20,9 % | 103.792.540 $ | +21.561.516 $ | +26,2 % | 82.231.024 $ | -3.023.868 $ | -3,5 % |
| INSMED Inc | INSM | 101.113.741 $ | +35.672.380 $ | +54,5 % | 65.441.361 $ | +26.586.864 $ | +68,4 % | ||||||
| Relay Therapeutics, Inc. | RLAY | 97.023.853 $ | +80.922.400 $ | +502,6 % | 16.101.453 $ | +16.101.453 $ | |||||||
| Viridian Therapeutics, Inc.\DE | VRDN | 22.901.415 $ | -71.787.502 $ | -75,8 % | 94.688.917 $ | +63.130.325 $ | +200,0 % | 31.558.592 $ | +25.302.444 $ | +404,4 % | 6.256.148 $ | -2.636.096 $ | -29,6 % |
| BOSTON SCIENTIFIC CORP | BSX | 93.347.650 $ | +63.082.350 $ | +208,4 % | 30.265.300 $ | +190.500 $ | +0,6 % | 30.074.800 $ | +16.960.400 $ | +129,3 % | |||
| AMICUS THERAPEUTICS, INC. | FOLD | 90.720.918 $ | +40.518.612 $ | +80,7 % | 50.202.306 $ | +7.726.790 $ | +18,2 % | 42.475.516 $ | -132.675.024 $ | -75,7 % | |||
| Zymeworks Inc. | ZYME | 87.892.353 $ | +2.007.842 $ | +2,3 % | 85.884.511 $ | +50.175.987 $ | +140,5 % | 35.708.524 $ | +19.703.835 $ | +123,1 % | 16.004.689 $ | -6.203.555 $ | -27,9 % |
| ARTIVION, INC. | AORT | 59.957.560 $ | -18.596.087 $ | -23,7 % | 78.553.647 $ | -6.973.153 $ | -8,2 % | 85.526.800 $ | -1.357.363 $ | -1,6 % | 86.884.163 $ | +18.214.943 $ | +26,5 % |
| Solid Biosciences Inc. | SLDB | 85.727.851 $ | +18.986.691 $ | +28,4 % | 66.741.160 $ | -6.271.776 $ | -8,6 % | 73.012.936 $ | +15.027.570 $ | +25,9 % | 57.985.366 $ | +13.930.776 $ | +31,6 % |
| Astria Therapeutics, Inc. | 84.894.147 $ | +37.680.290 $ | +79,8 % | 47.213.857 $ | +12.452.006 $ | +35,8 % | 34.761.851 $ | +129.709 $ | +0,4 % | ||||
| Dyne Therapeutics, Inc. | DYN | 84.646.051 $ | +16.597.906 $ | +24,4 % | 68.048.145 $ | +61.211.528 $ | +895,3 % | 6.836.617 $ | -14.558.536 $ | -68,0 % | 21.395.153 $ | -2.803.042 $ | -11,6 % |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 70.771.994 $ | +46.104.268 $ | +186,9 % | 24.667.726 $ | +24.667.726 $ | |||||||
| Oruka Therapeutics, Inc. | ORKA | 68.449.324 $ | +23.696.579 $ | +53,0 % | 44.752.745 $ | +20.368.701 $ | +83,5 % | 24.384.044 $ | +24.384.044 $ | ||||
| Nurix Therapeutics, Inc. | NRIX | 57.518.594 $ | -9.936.393 $ | -14,7 % | 67.454.987 $ | +54.369.770 $ | +415,5 % | 13.085.217 $ | +590.558 $ | +4,7 % | 12.494.659 $ | +8.959.729 $ | +253,5 % |
| BELITE BIO, INC | BLTE | 24.231.532 $ | -42.030.138 $ | -63,4 % | 66.261.670 $ | +62.577.358 $ | +1.698,5 % | 3.684.312 $ | +3.684.312 $ | ||||
| NEUROCRINE BIOSCIENCES INC | NBIX | 8.569.687 $ | -38.383.134 $ | -81,7 % | 46.952.821 $ | -16.225.198 $ | -25,7 % | 63.178.019 $ | +31.120.785 $ | +97,1 % | 32.057.234 $ | +20.991.704 $ | +189,7 % |
| Abivax S.A. | ABVX | 36.621.233 $ | -25.188.612 $ | -40,8 % | 61.809.845 $ | +28.817.026 $ | +87,3 % | 32.992.819 $ | +32.992.819 $ | ||||
| Penumbra Inc | PEN | 34.364.571 $ | -21.504.395 $ | -38,5 % | 55.868.966 $ | +47.452.272 $ | +563,8 % | 8.416.694 $ | +8.416.694 $ | ||||
| Akero Therapeutics, Inc. | 53.926.170 $ | +5.054.440 $ | +10,3 % | 48.871.730 $ | +16.772.709 $ | +52,3 % | |||||||
| Invivyd, Inc. | IVVD | 27.117.094 $ | -26.692.266 $ | -49,6 % | 53.809.360 $ | +53.809.360 $ | |||||||
| enGene Therapeutics Inc. | ENGN | 39.685.316 $ | -13.312.440 $ | -25,1 % | 52.997.756 $ | +38.673.634 $ | +270,0 % | 14.324.122 $ | +14.324.122 $ | ||||
| Omada Health, Inc. | OMDA | 9.884.168 $ | -27.929.919 $ | -73,9 % | 37.814.087 $ | -15.168.769 $ | -28,6 % | 52.982.856 $ | +8.581.017 $ | +19,3 % | 44.401.839 $ | +44.401.839 $ | |
| REPLIGEN CORP | RGEN | 33.053.341 $ | -18.651.207 $ | -36,1 % | 51.704.548 $ | +15.556.437 $ | +43,0 % | 36.148.111 $ | +15.501.031 $ | +75,1 % | 20.647.080 $ | +4.131.201 $ | +25,0 % |
| Moderna, Inc. | MRNA | 50.800.000 $ | +50.800.000 $ | ||||||||||
| Immunovant, Inc. | IMVT | 39.678.994 $ | -11.031.110 $ | -21,8 % | 50.710.104 $ | +25.113.317 $ | +98,1 % | 25.596.787 $ | -8.609.453 $ | -25,2 % | 34.206.240 $ | -14.398.950 $ | -29,6 % |
| INTUITIVE SURGICAL INC | ISRG | 39.377.305 $ | -10.416.500 $ | -20,9 % | 49.793.805 $ | +26.484.625 $ | +113,6 % | 23.309.180 $ | -1.208.936 $ | -4,9 % | 24.518.116 $ | +4.400.744 $ | +21,9 % |
| Nautilus Biotechnology, Inc. | NAUT | 48.865.538 $ | +24.306.827 $ | +99,0 % | 24.558.711 $ | +13.916.603 $ | +130,8 % | 10.642.108 $ | +1.511.306 $ | +16,6 % | 9.130.802 $ | -1.712.813 $ | -15,8 % |
| Sionna Therapeutics, Inc. | SION | 26.396.820 $ | -22.111.272 $ | -45,6 % | 48.508.092 $ | +13.830.820 $ | +39,9 % | 34.677.272 $ | +13.578.891 $ | +64,4 % | 21.098.381 $ | +8.011.865 $ | +61,2 % |
| CytomX Therapeutics, Inc. | CTMX | 47.464.473 $ | +6.226.885 $ | +15,1 % | 41.237.588 $ | +10.357.798 $ | +33,5 % | 30.879.790 $ | +15.004.214 $ | +94,5 % | 15.875.576 $ | +15.875.576 $ | |
| DANAHER CORP /DE/ | DHR | 45.784.000 $ | +45.784.000 $ | ||||||||||
| Alto Neuroscience, Inc. | ANRO | 45.182.395 $ | +13.420.200 $ | +42,3 % | 31.762.195 $ | +31.137.624 $ | +4.985,4 % | 624.571 $ | +624.571 $ | ||||
| IONIS PHARMACEUTICALS INC | IONS | 37.845.360 $ | +37.845.360 $ | ||||||||||
| Day One Biopharmaceuticals, Inc. | DAWN | 37.644.331 $ | +37.644.331 $ | ||||||||||
| Cidara Therapeutics, Inc. | 36.475.787 $ | +36.475.787 $ | |||||||||||
| SOLENO THERAPEUTICS INC | SLNO | 36.062.179 $ | -71.584.534 $ | -66,5 % | |||||||||
| Disc Medicine, Inc. | IRON | 35.793.502 $ | +28.347.502 $ | +380,7 % | |||||||||
| BRIGHT MINDS BIOSCIENCES INC. | DRUG | 27.549.386 $ | -7.513.206 $ | -21,4 % | 35.062.592 $ | +7.808.661 $ | +28,7 % | 27.253.931 $ | +16.269.715 $ | +148,1 % | 10.984.216 $ | -5.054.273 $ | -31,5 % |
| Corvus Pharmaceuticals, Inc. | CRVS | 33.538.412 $ | +28.206.616 $ | +529,0 % | 5.331.796 $ | -5.270.649 $ | -49,7 % | 10.602.445 $ | +4.848.065 $ | +84,2 % | 5.754.380 $ | +5.754.380 $ | |
| Caris Life Sciences, Inc. | CAI | 30.654.838 $ | -2.564.592 $ | -7,7 % | 33.219.430 $ | +3.876.515 $ | +13,2 % | 29.342.915 $ | +29.342.915 $ | ||||
| Jazz Pharmaceuticals plc | JAZZ | 32.138.500 $ | +3.238.500 $ | +11,2 % | 28.900.000 $ | +28.900.000 $ | |||||||
| Damora Therapeutics, Inc. | GLTO | 31.675.700 $ | +31.675.700 $ | ||||||||||
| PALISADE BIO, INC. | PALI | 15.624.261 $ | -12.693.239 $ | -44,8 % | 28.317.500 $ | +28.317.500 $ | |||||||
| RAPT Therapeutics, Inc. | RAPT | 27.972.894 $ | +23.230.371 $ | +489,8 % | 4.742.523 $ | +3.271.403 $ | +222,4 % | 1.471.120 $ | -3.919.995 $ | -72,7 % | |||
| PALVELLA THERAPEUTICS, INC. | PVLA | 27.872.260 $ | +3.103.880 $ | +12,5 % | 24.768.380 $ | +24.768.380 $ | |||||||
| X4 Pharmaceuticals, Inc | XFOR | 27.826.486 $ | +2.568.678 $ | +10,2 % | 25.257.808 $ | +25.257.808 $ | |||||||
| Guardant Health, Inc. | GH | 27.711.000 $ | +11.368.600 $ | +69,6 % | 16.342.400 $ | +16.342.400 $ | |||||||
| Aldeyra Therapeutics, Inc. | ALDX | 21.681.574 $ | -5.578.889 $ | -20,5 % | 27.260.463 $ | +11.742.716 $ | +75,7 % | 15.517.747 $ | -37.818.396 $ | -70,9 % | |||
| Axsome Therapeutics, Inc. | AXSM | 25.344.549 $ | -1.850.547 $ | -6,8 % | 27.195.096 $ | +9.111.191 $ | +50,4 % | 18.083.905 $ | -2.641.059 $ | -12,7 % | 20.724.964 $ | -20.691.165 $ | -50,0 % |
| Axogen, Inc. | AXGN | 23.101.947 $ | -2.562.955 $ | -10,0 % | 25.664.902 $ | +25.664.902 $ | |||||||
| Revolution Medicines, Inc. | RVMD | 25.596.350 $ | +25.361.375 $ | +10.793,2 % | 234.975 $ | +160.000 $ | +213,4 % | 74.975 $ | +9.300 $ | +14,2 % | 65.675 $ | +56.175 $ | +591,3 % |
| SAB Biotherapeutics, Inc. | SABS | 24.633.576 $ | +21.629.571 $ | +720,0 % | 3.004.005 $ | +3.004.005 $ | |||||||
| ADMA BIOLOGICS, INC. | ADMA | 4.209.769 $ | -11.904.687 $ | -73,9 % | 16.114.456 $ | -795.385 $ | -4,7 % | 16.909.841 $ | -6.826.311 $ | -28,8 % | 23.736.152 $ | -3.508.791 $ | -12,9 % |
| Kodiak Sciences Inc. | KOD | 23.735.244 $ | +13.347.219 $ | +128,5 % | 10.388.025 $ | +10.388.025 $ | |||||||
| Beta Bionics, Inc. | BBNX | 8.446.299 $ | -9.925.405 $ | -54,0 % | 18.371.704 $ | +12.848.957 $ | +232,7 % | 5.522.747 $ | -17.680.185 $ | -76,2 % | 23.202.932 $ | +3.697.170 $ | +19,0 % |
| TENAX THERAPEUTICS, INC. | TENX | 23.150.034 $ | +17.796.893 $ | +332,5 % | 5.353.141 $ | +5.353.141 $ | |||||||
| Evolus, Inc. | EOLS | 5.289.003 $ | -17.504.301 $ | -76,8 % | 22.793.304 $ | -26.880.274 $ | -54,1 % | ||||||
| BIOGEN INC. | BIIB | 21.822.760 $ | +21.822.760 $ | ||||||||||
| Orchestra BioMed Holdings, Inc. | OBIO | 21.411.101 $ | +132.989 $ | +0,6 % | 21.278.112 $ | +8.152.573 $ | +62,1 % | 13.125.539 $ | +817.489 $ | +6,6 % | 12.308.050 $ | -7.348.090 $ | -37,4 % |
| iRhythm Holdings, Inc. | IRTC | 12.395.169 $ | -6.768.351 $ | -35,3 % | 19.163.520 $ | -1.991.250 $ | -9,4 % | 21.154.770 $ | +21.154.770 $ | ||||
| Rapport Therapeutics, Inc. | RAPP | 21.087.051 $ | +640.227 $ | +3,1 % | 20.446.824 $ | +8.450.311 $ | +70,4 % | 11.996.513 $ | +11.996.513 $ | ||||
| Aquestive Therapeutics, Inc. | AQST | 4.826.867 $ | -16.192.086 $ | -77,0 % | 21.018.953 $ | +13.768.663 $ | +189,9 % | 7.250.290 $ | -3.558.613 $ | -32,9 % | |||
| Mirum Pharmaceuticals, Inc. | MIRM | 20.501.460 $ | +20.501.460 $ | ||||||||||
| GRAIL, Inc. | GRAL | 20.314.102 $ | +20.314.102 $ | ||||||||||
| DBV Technologies S.A. | DBVT | 20.146.128 $ | +20.146.128 $ | ||||||||||
| Adagio Medical Holdings, Inc. | ADGM | 11.012.382 $ | +740.743 $ | +7,2 % | 10.271.639 $ | -8.888.937 $ | -46,4 % | 19.160.576 $ | +6.321.027 $ | +49,2 % | 12.839.549 $ | +4.940.552 $ | +62,5 % |
| LeonaBio, Inc. | LONA | 19.113.830 $ | +5.038.763 $ | +35,8 % | 14.075.067 $ | +11.838.242 $ | +529,2 % | 2.236.825 $ | +605.130 $ | +37,1 % | 1.631.695 $ | +92.391 $ | +6,0 % |
| Anteris Technologies Global Corp. | AVR | 19.011.392 $ | +10.650.767 $ | +127,4 % | 8.360.625 $ | +687.540 $ | +9,0 % | 7.673.085 $ | +1.210.642 $ | +18,7 % | 6.462.443 $ | -1.327.157 $ | -17,0 % |
| INSULET CORP | PODD | 18.972.388 $ | +170.300 $ | +0,9 % | |||||||||
| SUTRO BIOPHARMA, INC. | STRO | 17.818.297 $ | +17.818.297 $ | ||||||||||
| CVS HEALTH Corp | CVS | 17.459.200 $ | +17.459.200 $ | ||||||||||
| Tango Therapeutics, Inc. | TNGX | 16.906.561 $ | +12.361.071 $ | +271,9 % | 4.545.490 $ | +4.545.490 $ | |||||||
| Contineum Therapeutics, Inc. | CTNM | 16.398.032 $ | -342.255 $ | -2,0 % | 16.740.287 $ | +8.343.831 $ | +99,4 % | 8.396.456 $ | +5.619.497 $ | +202,4 % | 2.776.959 $ | -7.282.959 $ | -72,4 % |
| Outset Medical, Inc. | OM | 3.199.998 $ | +108.333 $ | +3,5 % | 3.091.665 $ | -8.674.996 $ | -73,7 % | 11.766.661 $ | -4.241.665 $ | -26,5 % | 16.008.326 $ | +6.791.664 $ | +73,7 % |
| GLAUKOS Corp | GKOS | 15.807.400 $ | +15.807.400 $ | ||||||||||
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | 15.173.000 $ | +15.173.000 $ | ||||||||||
| DEXCOM INC | DXCM | 14.983.558 $ | +2.827.938 $ | +23,3 % | |||||||||
| Savara Inc | SVRA | 14.472.000 $ | +14.472.000 $ | ||||||||||
| Oculis Holding AG | OCS | 13.130.860 $ | +3.269.135 $ | +33,1 % | 9.861.725 $ | +9.861.725 $ | |||||||
| Septerna, Inc. | SEPN | 12.076.501 $ | +1.891.826 $ | +18,6 % | 10.184.675 $ | +4.461.548 $ | +78,0 % | 5.723.127 $ | +5.723.127 $ | ||||
| Inhibikase Therapeutics, Inc. | IKT | 3.889.200 $ | -7.225.014 $ | -65,0 % | 11.114.214 $ | +2.331.274 $ | +26,5 % | 8.782.940 $ | -1.810.031 $ | -17,1 % | 10.592.971 $ | -2.382.779 $ | -18,4 % |
| Evommune, Inc. | EVMN | 10.307.567 $ | +10.307.567 $ | ||||||||||
| Phathom Pharmaceuticals, Inc. | PHAT | 10.276.750 $ | +10.276.750 $ | ||||||||||
| Viking Therapeutics, Inc. | VKTX | 2.775.089 $ | -7.313.461 $ | -72,5 % | 10.088.550 $ | -2.203.921 $ | -17,9 % | ||||||
| Gossamer Bio, Inc. | GOSS | 9.732.974 $ | -294.682 $ | -2,9 % | 10.027.656 $ | +10.027.656 $ | |||||||
| Neumora Therapeutics, Inc. | NMRA | 9.952.989 $ | +9.952.989 $ | ||||||||||
| Ultragenyx Pharmaceutical Inc. | RARE | 9.817.200 $ | +9.817.200 $ | ||||||||||
| MapLight Therapeutics, Inc. | MPLT | 9.660.750 $ | +9.660.750 $ | ||||||||||
| Kymera Therapeutics, Inc. | KYMR | 5.441.642 $ | -4.168.812 $ | -43,4 % | 9.610.454 $ | +441.428 $ | +4,8 % | 9.169.026 $ | +9.169.026 $ | ||||
| Xenon Pharmaceuticals Inc. | XENE | 8.999.453 $ | +937.694 $ | +11,6 % | 8.061.759 $ | +1.777.001 $ | +28,3 % | 6.284.758 $ | -4.629.862 $ | -42,4 % | |||
| Opus Genetics, Inc. | IRD | 8.353.081 $ | -340.169 $ | -3,9 % | 8.693.250 $ | +1.557.000 $ | +21,8 % | 7.136.250 $ | +3.061.667 $ | +75,1 % | 4.074.583 $ | -171.702 $ | -4,0 % |
| KESTRA MEDICAL TECHNOLOGIES, LTD. | KMTS | 7.558.200 $ | +2.574.200 $ | +51,6 % | |||||||||
| CAPRICOR THERAPEUTICS, INC. | CAPR | 6.987.006 $ | -460.494 $ | -6,2 % | 7.447.500 $ | +7.447.500 $ | |||||||
| CRESCENT BIOPHARMA, INC. | CBIO | 3.801.525 $ | -1.579.191 $ | -29,3 % | 5.380.716 $ | -13.611 $ | -0,3 % | 5.394.327 $ | -1.928.165 $ | -26,3 % | 7.322.492 $ | +7.322.492 $ | |
| BillionToOne, Inc. | BLLN | 7.247.639 $ | +1.288.705 $ | +21,6 % | 5.958.934 $ | +5.958.934 $ | |||||||
| Janux Therapeutics, Inc. | JANX | 7.153.246 $ | +392.199 $ | +5,8 % | 6.761.047 $ | -19.440.077 $ | -74,2 % | ||||||
| Twist Bioscience Corp | TWST | 7.128.000 $ | +7.128.000 $ | ||||||||||
| Tempus AI, Inc. | TEM | 6.860.350 $ | +6.860.350 $ | ||||||||||
| Surrozen, Inc./DE | SRZN | 6.682.218 $ | +6.682.218 $ | ||||||||||
| Agomab Therapeutics NV | AGMB | 6.294.000 $ | +6.294.000 $ | ||||||||||
| Krystal Biotech, Inc. | KRYS | 4.314.450 $ | -1.864.100 $ | -30,2 % | 6.178.550 $ | +6.178.550 $ | |||||||
| Biohaven Ltd. | BHVN | 5.645.000 $ | +5.645.000 $ | ||||||||||
| PepGen Inc. | PEPG | 5.402.454 $ | +1.568.455 $ | +40,9 % | 3.833.999 $ | +3.833.999 $ | |||||||
| GLOBUS MEDICAL INC | GMED | 5.223.270 $ | +5.223.270 $ | ||||||||||
| Tectonic Therapeutic, Inc. | TECX | 5.215.000 $ | +5.215.000 $ | ||||||||||
| enVVeno Medical Corp | NVNO | 564.298 $ | -1.029.388 $ | -64,6 % | 1.593.686 $ | -3.533.328 $ | -68,9 % | 5.127.014 $ | +5.127.014 $ | ||||
| Heartflow, Inc. | HTFL | 5.049.000 $ | +5.049.000 $ | ||||||||||
| Cogent Biosciences, Inc. | COGT | 4.660.446 $ | +359.613 $ | +8,4 % | 4.300.833 $ | +4.300.833 $ | |||||||
| OCULAR THERAPEUTIX, INC | OCUL | 4.235.000 $ | -2.477.631 $ | -36,9 % | |||||||||
| BridgeBio Oncology Therapeutics, Inc. | BBOT | 4.226.760 $ | -270.640 $ | -6,0 % | |||||||||
| Olema Pharmaceuticals, Inc. | OLMA | 4.142.825 $ | +4.142.825 $ | ||||||||||
| Schrodinger, Inc. | SDGR | 3.618.912 $ | +3.618.912 $ | ||||||||||
| KING LUTHER CAPITAL MANAGEMENT CORP | 3.306.415 $ | +1.401.415 $ | +73,6 % | 1.905.000 $ | +590.000 $ | +44,9 % | |||||||
| Apellis Pharmaceuticals, Inc. | APLS | 3.256.860 $ | +3.256.860 $ | ||||||||||
| Edesa Biotech, Inc. | EDSA | 2.945.740 $ | +2.945.740 $ | ||||||||||
| Pyxis Oncology, Inc. | PYXS | 2.615.842 $ | +2.615.842 $ | ||||||||||
| Avalo Therapeutics, Inc. | AVTX | 2.085.228 $ | -451.125 $ | -17,8 % | 2.536.353 $ | +761.185 $ | +42,9 % | 1.775.168 $ | +1.078.230 $ | +154,7 % | 696.938 $ | -3.468.262 $ | -83,3 % |
| Lyra Therapeutics, Inc. | LYRA | 1.497.864 $ | -788.280 $ | -34,5 % | 2.286.144 $ | +678.691 $ | +42,2 % | ||||||
| Connect Biopharma Holdings Ltd | CNTB | 2.076.864 $ | -158.539 $ | -7,1 % | 2.235.403 $ | +2.235.403 $ | |||||||
| Adaptive Biotechnologies Corp | ADPT | 2.116.700 $ | -4.800.422 $ | -69,4 % | |||||||||
| CORCEPT THERAPEUTICS INC | CORT | 2.015.500 $ | +2.015.500 $ | ||||||||||
| ARS Pharmaceuticals, Inc. | SPRY | 2.010.000 $ | +2.010.000 $ | ||||||||||
| TRINITY BIOTECH PLC | TRIB | 1.861.600 $ | +698.100 $ | +60,0 % | 1.163.500 $ | +1.163.500 $ | |||||||
| Immix Biopharma, Inc. | IMMX | 1.772.661 $ | +1.772.661 $ | ||||||||||
| Lexeo Therapeutics, Inc. | LXEO | 1.388.562 $ | +460.058 $ | +49,5 % | 928.504 $ | +366.367 $ | +65,2 % | 562.137 $ | +76.910 $ | +15,9 % | |||
| CUMBERLAND PHARMACEUTICALS INC | CPIX | 640.179 $ | -717.347 $ | -52,8 % | 1.357.526 $ | +1.357.526 $ | |||||||
| Medline Inc. | MDLN | 1.246.000 $ | +70.000 $ | +6,0 % | 1.176.000 $ | +1.176.000 $ | |||||||
| uniQure N.V. | QURE | 1.167.400 $ | +1.167.400 $ | ||||||||||
| PALATIN TECHNOLOGIES INC | PTNT | 1.079.082 $ | +2.482 $ | +0,2 % | 1.076.600 $ | +1.076.600 $ | |||||||
| Forte Biosciences, Inc. | FBRX | 881.723 $ | +881.723 $ | ||||||||||
| BIODESIX INC | BDSX | 739.119 $ | -81.520 $ | -9,9 % | 820.639 $ | +207.605 $ | +33,9 % | 613.034 $ | -745.641 $ | -54,9 % | |||
| LENZ Therapeutics, Inc. | LENZ | 800.000 $ | +800.000 $ | ||||||||||
| IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 416.909 $ | -41.913.345 $ | -99,0 % | |||||||||
| EXAGEN INC. | XGN | 344.679 $ | +344.679 $ | ||||||||||
| Apyx Medical Corp | APYX | 321.000 $ | -16.500 $ | -4,9 % | 337.500 $ | +132.000 $ | +64,2 % | ||||||
| KALA BIO, Inc. | KALA | 262.881 $ | -1.327.824 $ | -83,5 % | |||||||||
| Ensysce Biosciences, Inc. | ENSC | 46.670 $ | -33.063 $ | -41,5 % | 79.733 $ | -125.665 $ | -61,2 % | 205.398 $ | +12.133 $ | +6,3 % | 193.265 $ | -28.600 $ | -12,9 % |
| SURROZEN INC | 2.667 $ | -134.120.333 $ | -100,0 % | 3.333 $ | +366 $ | +12,3 % | 2.967 $ | -24.876.033 $ | -100,0 % | 3.017 $ | -1.983 $ | -39,7 % | |
| 5.117.574.591 $ | +466.341.338 $ | +170,5 % | 5.610.284.266 $ | +2.445.795.663 $ | +49.239,2 % | 3.463.098.749 $ | +886.603.696 $ | +74,9 % | 2.697.358.275 $ | +172.807.331 $ | +12.502,1 % | ||